The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of sentinel lymph node biopsies (SLNB) in melanoma.
Diwakar Davar
No relevant relationships to disclose
Melissa Saul
No relevant relationships to disclose
Kerry Trent
No relevant relationships to disclose
Matthew Peter Holtzman
No relevant relationships to disclose
Howard Edington
No relevant relationships to disclose
Hussein Abdul-Hassan Tawbi
No relevant relationships to disclose
Ahmad A. Tarhini
No relevant relationships to disclose
John M. Kirkwood
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Vical; ZIOPHARM Oncology
Research Funding - Prometheus